These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms. Dusting GJ, Akita K, Hickey H, Smith M, Gurevich V. Br J Pharmacol; 1999 Sep; 128(2):337-44. PubMed ID: 10510443 [Abstract] [Full Text] [Related]
4. Effects of cyclosporin A and FK506 on nitric oxide and tetrahydrobiopterin synthesis in bacterial lipopolysaccharide-treated J774 macrophages. Hattori Y, Nakanishi N. Cell Immunol; 1995 Oct 01; 165(1):7-11. PubMed ID: 7545550 [Abstract] [Full Text] [Related]
6. Diethyldithiocarbamate ameliorates the effect of lipopolysaccharide on both increased nitrite production by vascular smooth muscle cells and decreased contractile response of aortic rings. Loegering DJ, Richard CA, Davison CB, Wirth GA. Life Sci; 1995 Oct 01; 57(2):169-76. PubMed ID: 7541501 [Abstract] [Full Text] [Related]
7. Induction of L-arginine transport and nitric oxide synthase in vascular smooth muscle cells: synergistic actions of pro-inflammatory cytokines and bacterial lipopolysaccharide. Wileman SM, Mann GE, Baydoun AR. Br J Pharmacol; 1995 Dec 01; 116(8):3243-50. PubMed ID: 8719803 [Abstract] [Full Text] [Related]
8. Presence of excess tetrahydrobiopterin during nitric oxide production from inducible nitric oxide synthase in LPS-treated rat aorta. Shimizu S, Ishii M, Kawakami Y, Kiuchi Y, Momose K, Yamamoto T. Life Sci; 1999 Dec 01; 65(26):2769-79. PubMed ID: 10622266 [Abstract] [Full Text] [Related]
9. Inhibitory effect of FK 506 and cyclosporin A on nitric oxide production by LPS-treated cultured rat macrophages. Strestíková P, Otová B, Filipec M, Farghali H. Physiol Res; 2000 Dec 01; 49(6):725-8. PubMed ID: 11252540 [Abstract] [Full Text] [Related]
10. Therapeutic concentrations of tacrolimus do not interfere with endothelial nitric oxide synthesis in rat thoracic aortas and coronary arteries. Can C, Erol A, Cinar M, Olukman M, Ulker S, Evinç A. J Cardiovasc Pharmacol; 2007 Oct 01; 50(4):399-405. PubMed ID: 18049307 [Abstract] [Full Text] [Related]
11. Effects of human cathelicidin antimicrobial peptide LL-37 on lipopolysaccharide-induced nitric oxide release from rat aorta in vitro. Ciornei CD, Egesten A, Bodelsson M. Acta Anaesthesiol Scand; 2003 Feb 01; 47(2):213-20. PubMed ID: 12631052 [Abstract] [Full Text] [Related]
13. Immunosuppressant FK506 inhibits inducible nitric oxide synthase gene expression at a step of NF-kappaB activation in rat hepatocytes. Kaibori M, Sakitani K, Oda M, Kamiyama Y, Masu Y, Nishizawa M, Ito S, Okumura T. J Hepatol; 1999 Jun 01; 30(6):1138-45. PubMed ID: 10406194 [Abstract] [Full Text] [Related]
15. Nitric oxide release from rat aortic smooth muscle cells is not attenuated by angiotensin converting enzyme inhibitors. Ikeda U, Shimada K. Eur J Pharmacol; 1994 Nov 15; 269(3):319-23. PubMed ID: 7534708 [Abstract] [Full Text] [Related]
19. Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages. Evidence of a direct effect on nitric oxide synthase activity. Conde M, Andrade J, Bedoya FJ, Santa Maria C, Sobrino F. Immunology; 1995 Mar 15; 84(3):476-81. PubMed ID: 7538492 [Abstract] [Full Text] [Related]
20. Differential effects of some cell signalling inhibitors upon nitric oxide synthase expression and nuclear factor-kappaB activation induced by lipopolysaccharide in rat aortic smooth muscle cells. Zhou J, Struthers AD, Lyles GA. Pharmacol Res; 1999 May 15; 39(5):363-73. PubMed ID: 10328994 [Abstract] [Full Text] [Related] Page: [Next] [New Search]